Old Web
English
Sign In
Acemap
>
Paper
>
MK2206, a selective AKT inhibitor, modulates ovarian cancer cell line sensitivity to carboplatin plus paclitaxel
MK2206, a selective AKT inhibitor, modulates ovarian cancer cell line sensitivity to carboplatin plus paclitaxel
2012
N. Bou Zgheib
D. Marchion
Y. Xiong
X. Stickles
P. Judson
Ardeshir Hakam
J. Gonzalez Bosquet
R. Wenham
Sachin M. Apte
J.M. Lancaster
Keywords:
Carboplatin
Ovarian cancer
Protein kinase B
General surgery
Cancer research
Paclitaxel
Medicine
Cell culture
akt inhibitor
ovarian cancer cell line
Gynecology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]